Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Pacific Biosciences Of California, Inc. publishes a filing, an earnings call transcript or a press release.

Get PACB alerts

About Christian O. Henry

Christian O. Henry is recorded as Board Member at Pacific Biosciences Of California, Inc. (PACB) since June 3, 2026 and Chairman at Pacific Biosciences Of California, Inc. (PACB) since March 2, 2020. Pacific Biosciences Of California, Inc. reported in an 8-K filed August 5, 2026 that Christian O. Henry resigned as President and Chief Executive Officer, effective August 5, 2026. Pacific Biosciences Of California, Inc. reported in an 8-K filed June 4, 2026 that Christian O. Henry was appointed Class III Director, effective June 3, 2026. The proxy statement of Pacific Biosciences Of California, Inc. reports total compensation of $4,309,846 for Christian O. Henry in fiscal 2025, including a base salary of $748,250. Disclosed compensation is on record for 5 fiscal years. Pacific Biosciences Of California, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Pacific Biosciences Of California, Inc. includes Christian Henry (CEO, CFO and Board Member), Mark Van Oene (CEO, CFO, COO and Board Member), John F. Milligan (Chairman and Board Member) and 7 others.

“Effective as of August 5, 2026, Employee agrees that in mutual agreement with the board of directors Employee resigned as the Company's President and Chief Executive Officer and from any officer, director, manager, or similar positions Employee occupied with the Company or any subsidiary or affiliate of Company, other than as a member of the Company's board of directors as covered elsewhere in this Agreement and Senior Business Advisor as provided in Section 1(a) and agrees to execute any necessary -2- documents or other forms necessary to effectuate or document Employee's resignation as a matter of local, state, federal, or international law.”
Pacific Biosciences Of California, Inc. Form 8-K, filed August 5, 2026 · Read the filing
“Each director nominee was duly elected to serve until the 2027 annual meeting of stockholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal.”
Pacific Biosciences Of California, Inc. Form 8-K, filed June 4, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Pacific Biosciences Of California, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Pacific Biosciences Of California, Inc. (PACB) $748,250 $4,309,846
2024 Pacific Biosciences Of California, Inc. (PACB) $725,025 $9,181,620
2023 Pacific Biosciences Of California, Inc. (PACB) $695,125 $8,046,575
2022 Pacific Biosciences Of California, Inc. (PACB) $666,667 $6,616,251
2021 Pacific Biosciences Of California, Inc. (PACB) $650,000 $2,866,931

Recent activity